Therapeutic discovery and development rely on numerous analytical techniques in order to best position candidate drugs for commercial success. Different analytical technologies are utilized for their respective strengths in maximizing understanding of candidate properties.
Watch Now
labroots.com
It's estimated than less than 10% of investigational anti-cancer drugs successfully achieve FDA approval for clinical use. This is often attributed to the fact that it’s difficult to identify patients whose tumors are most likely to respond to a specific treatment. Patient derived xenografts (PDXs) are bringing new hope when it comes to this challenging task, yet finding the ideal animal model to grow the PDX tumors to test new therapies can be challenging. The new B-NDG mouse model is our newest triple immunodeficient mouse with proven performance in cancer and immuno-oncology research.
Watch Now
Workcast
Connective tissue-specific stem and progenitor cells (also known asa mesenchymal stormal/stem cells or MSCs) have been the subject of clinical testing for various conditions, but the outcomes of advanced clinical trials have fallen short of expectations raised by encouraging pre-clinical animal data in a wide array of disease models.
Watch Now
mantralabsglobal.com
Mixed Reality (MR) also known as “hybrid reality” and “extended reality,” has the potential to change just about every industry, healthcare being no exception. A combination of Virtual Reality (VR), Augmented Reality (AR), and Artificial Intelligence (AI); MR is emerging as a tech to create experiences that blend the real-life environment with digital elements.
Watch Now